StockData
Glucose Health, Inc. logo

Glucose Health, Inc. (GLUC) stock

GLUCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2017, quý kết thúc ngày Sep 30, 2017Last filing: 10-Q on Nov 14, 2017
$0.44+0.10 (+28.76%)

Close on Oct 19, 2026Market cap $1.82MP/E –Yield –

Glucose Health, Inc. saw revenue fall 70.6% to $88.13K over the twelve months to Sep 30, 2017. At the latest close the market valued the company at $1.82M.

Revenue
$88.13K
-70.6% vs. a year earlier
Operating income
-$32.45K
TTM Q3 2017
EPS, diluted
-$0.04
TTM Q3 2017

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2017

Valuation

Market cap
$1.82M
P/E ratio
–
Price to sales
20.71
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$88.13K
Net income
-$85.06K
EPS, diluted
-$0.04
Book value per share
-$0.10
Diluted shares
4M

Trading

Previous close
$0.34
Open
$0.39
Day's range
$0.39 – $0.44
Volume
5,000
Average volume (20 days)
15,177

Market cap history

Month-end market cap since 2011, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodGLUCS&P 500DifferenceGLUC per yearS&P 500 per year
1 month+26.4%+0.6%+25.8 pts
3 months+37.5%+3.4%+34.1 pts
Year to date+106.5%+13.3%+93.2 pts
1 year+1153.3%+16.6%+1136.7 pts
3 years+100.0%+86.4%+13.6 pts+26.0%+23.1%
5 years-80.2%+81.9%−162.0 pts-27.7%+12.7%
10 years+645.6%+318.9%+326.7 pts+22.3%+15.4%

Eight years at a glance

Fiscal years 2009 to 2016 and trailing twelve months, USD

Revenue

$88.13K-70.6% YoY

Gross profit

$57.63K+205.9% YoY

Operating income

-$32.45K

Net income

-$85.06K

EPS, diluted

-$0.04
Reported periodTrailing twelve months

About Glucose Health

Medicinal Chemicals & Botanical Products

Glucose Health, Inc. manufactures dietary supplements designed to support healthy blood sugar, triglyceride, and cholesterol levels, as well as promote digestive health. Its primary offering is Glucose Health®, a dietary supplement formulated with soluble fiber and plant-based extracts. The company targets consumer markets concerned with pre-diabetes and Type-2 diabetes. It distributes its products primarily through national and regional pharmacy retailers, while also offering direct sales to consumers via dedicated websites and online marketplaces.

Company profile, executives and history

Glucose Health stock: common questions

What is Glucose Health's stock price?

GLUC closed at $0.44 on Oct 19, 2026, up 28.76% on the day.

What is Glucose Health's market cap?

Glucose Health was worth $1.82M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

What is GLUC's P/E ratio?

Glucose Health lost money over the twelve months to Sep 30, 2017 (diluted EPS -$0.04), so it has no meaningful P/E ratio.

How much revenue does Glucose Health make?

Glucose Health reported revenue of $88.13K for the twelve months to Sep 30, 2017, down 70.6% from a year earlier.

Does Glucose Health pay a dividend?

No. Glucose Health has not paid a cash dividend over the last twelve months.

How has GLUC stock performed over the past year?

Including dividends, GLUC returned +1153.3% over the past year, against +16.6% for the S&P 500.

Who are Glucose Health's competitors?

Companies most similar to Glucose Health by business, industry and size include HYEX, FTLF, MTEX, NTRR, NAII.

See a number that looks wrong?